The $100+ billion cannabis industry is fueled by innovative strategies and visionary leaders. Each week, we explore the journeys of CEOs from publicly traded giants, world-renowned scientists, and underground legacy growers shaping the future of this transformative market.
Bryan and Kellan uncover how these pioneers built their businesses, navigated failures and found success in this rapidly growing space. Join us to explore the lessons and insights driving the cannabis industry forward.
Site
RSS
Apple
Données mises à jour le 04/07/2026
Classements récents
Dernières positions dans les classements Apple Podcasts et Spotify.
Liens partagés entre épisodes et podcasts
Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.
Robotics vs Automation in Cannabis Manufacturing ft. Nohtal Partansky
Épisode 287
jeudi 22 janvier 2026 • Durée 51:01
Most cannabis automation fails for a simple reason. It optimizes motion instead of understanding.
Automation executes. Robotics adapts. That distinction matters in an industry where variability is unavoidable and capital is limited.
This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing.
This week, we sit down with Nohtal Partansky to cover:
Why automation breaks under variability
Automation vs robotics, clearly defined
How to avoid expensive missteps
Chapters
00:00 Understanding Automation in Cannabis Manufacturing
03:02 The Role of Robotics vs. Automation
05:45 Consultative Approach to Automation
08:54 Challenges in Cultivation Automation
11:59 Designing for Variability in Automation
15:01 Iterative Development and Customer Feedback
18:08 Identifying Design vs. Customer Issues
21:06 Adapting to Environmental Nuances
23:55 Conveying Value in Automation Solutions
27:09 Strategic Approaches to Automation in Supply Chain
30:10 Optimizing Pre-Roll Production Processes
33:44 Understanding Tolerance Levels in Manufacturing
36:39 Intellectual Property in the Cannabis Industry
42:26 Innovations in Cannabis Manufacturing
45:32 Challenges in Automation and Scaling
50:51 Improving Processes and Training in Cannabis Operations
Summary
In this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Building Jaunty Into One of New York’s Top Cannabis Brands ft. Nicolas Guarino
Épisode 286
jeudi 15 janvier 2026 • Durée 56:57
Jaunty’s rise to the top of the New York cannabis market was not an overnight success. It was built through discipline in a market uniquely designed
New York’s rollout remains unforgiving. One store openings, supply and demand constraints, and continuous price compression forced every decision into the open.
This week we sit down with Nicolas Guarino, Co-Founder and CEO of Jaunty, to break down what it actually takes to survive and scale in one of the most interesting cannabis markets in the country.
This week we sit down with Nick to discuss:
Why consistency becomes the only real moat as prices fall
How New York’s rollout punished assumptions and rewarded preparedness
Capital discipline, supplier trust, and avoiding overspend death spirals
Chapters
00:00 Introduction to Jaunty and Nicolas Guarino
03:06 The Journey into the Cannabis Industry
06:07 Challenges and Lessons Learned in CBD
09:00 Transitioning to Recreational Cannabis
11:54 Building a Brand in a Competitive Market
15:07 Navigating Market Dynamics and Growth Challenges
18:07 The Importance of Support and Resilience
20:49 Understanding Market Economics and Consumer Behavior
23:55 Future Prospects for Cannabis in New York
31:48 The Economics of Cannabis Production
36:29 The Importance of Consistency in Branding
41:11 Navigating Challenges in Cannabis Operations
46:10 Strategic Planning for Future Growth
How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick
Épisode 285
jeudi 8 janvier 2026 • Durée 49:59
Before CBD was discussed by a President in the Oval Office, it was a medical necessity.
The Charlotte Figi story is well documented — and powerful. Not because it was emotional, but because it forced a serious medical conversation.
Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.
Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.
This week, we sit down with Bill Morachnick to break down:
Why CBD earned acceptance through medical trust, not consumer marketing
How physician comfort, reimbursement pathways, and standards changed the conversation
CBD in the Oval Office — and what that signals for the future of cannabis
Chapters
00:00 Introduction to Charlotte's Web and Bill Morachnick
03:00 The Inspiring Story of Charlotte Figi
05:51 The Executive Order and Its Implications
08:59 The Role of Education in CBD Acceptance
12:12 Challenges and Misconceptions in the Cannabis Industry
15:03 The Future of CBD and Medical Recommendations
18:06 The Impact of Federal Reimbursement on CBD
21:08 Defloria and the Future of Cannabis Research
24:01 Navigating Regulatory Changes and Industry Challenges
27:03 The Importance of Quality and Consistency in CBD Products
The Playbook Behind Consistent Cannabis Products at Scale ft. Ryan Crandall
Épisode 284
vendredi 2 janvier 2026 • Durée 46:42
Everyone wants their product and brand to be known for consistency . Almost no one is willing to do the difficult work that makes consistency possible.
This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:
Why most cannabis brands fail at scale — and howprocess control, not an artisanal mindset, determines who lasts
How MariMed engineers consistency across states by centralizing inputs & testing aggressively,
What it actually takes to make effects-based products consistent and repeatable
Chapters
00:00 Introduction to the Cannabis Industry and Edibles
03:05 The Evolution of Edibles: From Early Days to Now
06:01 Ensuring Consistency Across State Lines
09:09 Quality Control and Testing in Edibles
12:01 Consumer Education and Brand Trust
15:13 MariMed Brand Portfolio and Market Strategy
18:06 Role of R&D in Product Development
21:00 Future Trends and Innovations in Edibles
24:03 Building Relationships with Budtenders and Consumers
27:58 Exploring Cannabinoids: THCV and CBG Effects
30:06 Understanding Edible Experiences and Consumer Expectations
32:00 Responsible Product Development in the Cannabis Industry
33:52 Brand Strategy and Market Penetration in New States
35:51 Innovative Products: Vibations and Consumer Convenience
38:04 Navigating the Hemp Market and Brand Expansion
39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis
Schedule III Changes Everything — This Is Just the Beginning
Épisode 283
vendredi 19 décembre 2025 • Durée 38:13
Schedule III isn’t the finish line. It’s the starting gun.
The EO said a lot — but most operators aren’t ready for what it actually means.
This week we sit down with Zach Edge and Dr. Matthew Moore to break down:
Why Schedule III is guidance, not rules — and why the real impact comes during rulemaking
What GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operators
Which parts of the supply chain face the biggest disruption as cannabis moves forward
Chapters
00:00 Historic Changes in Cannabis Scheduling
03:13 The Impact of Hemp in the New Landscape
06:07 Strategic Shifts for Cannabis Operators
08:59 Navigating Regulatory Changes
11:58 The Role of Pharmacies in the New Market
15:04 Global Trade and Competition in Cannabis
17:53 Research Opportunities and Challenges
21:02 Veterans and the Future of CBD
24:02 The Supply Chain Dynamics
26:47 The Future of Hemp and CBD Products
29:56 Final Thoughts on the Cannabis Industry
Summary:
In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves.
Inside SNDL’s Hidden Scale: Global Reach & Supply Chain Powerhouse ft. Tyler Robson
Épisode 282
jeudi 11 décembre 2025 • Durée 33:22
SNDL is much bigger than most people realize — with global distribution, massive extraction capacity, and a diversified retail and manufacturing engine that touches nearly every part of the cannabis supply chain.
This week we sit down with Tyler Robson, President of SNDL, to break down:
• How SNDL became a global manufacturing and retail powerhouse • Why extraction and derivatives are their true competitive edge • How they operate across countries with completely different rules and product formats
Chapters
00:00 Introduction to Sundial and Tyler Robson
02:08 The Complexity of Extraction and Manufacturing
04:38 Merging Sundial and Valens: Challenges and Strategies
06:11 Sundial's Operations and Global Reach
07:39 Firefighting and Problem Solving in Leadership
09:52 Data-Driven Decision Making
12:44 Navigating Different Regulatory Environments
13:55 Core Competencies and Operational Efficiencies
15:46 Staying Focused in a Distracted Industry
16:18 Sundial's Market Position and Brand Partnerships
17:10 Strategic Focus on Texas and Florida
19:09 Resource Planning and Flexibility
20:42 Continuous Improvement in Manufacturing
22:34 Synergies Between Liquor and Cannabis
24:48 Future of Cannabis and Liquor Co-Mingling
26:30 Emerging International Markets
28:23 Potential Partnerships and Collaborations
You’re Thinking About Debt Wrong: The Secret to Smart Financing ft. Adam Stettner
Épisode 281
vendredi 5 décembre 2025 • Durée 53:52
Most operators think debt is dangerous. But what if the real problem is how we think about it? The opposite is true: when used correctly, debt is the single biggest growth lever in cannabis. Every major industry scales on borrowed capital — cannabis is the only one still trying to do it alone.
This week we sit down with Adam Stettner to discuss: • Why debt — used properly — compounds growth • The difference between smart leverage and over-leverage • How operators can fix cash-flow bottlenecks and scale predictably
Chapters
00:00 Introduction to Adam Stettner and FundCanna.
03:05 Adam's Journey into the Cannabis Industry
06:12 Understanding Underwriting in Cannabis Financing
09:05 The Importance of Client-Centric Financing
11:56 Navigating Complex Variables in Cannabis Lending
14:57 Building Infrastructure for Cannabis Financing
17:48 Segmenting the Cannabis Industry for Better Insights
20:55 The Unique Challenges of Cannabis Lending
24:12 The Role of Transparency in Client Relationships
28:23 Building Partnerships for Success
29:29 Funding Options for Operational Efficiency
32:29 Understanding Technology and Business Operations
37:54 Navigating Debt and Financial Strategies
42:10 Using Debt to Accelerate Growth
52:46 Exploring Funding Opportunities
Summary
In this episode, Bryan Fields and Kellen Finney welcome Adam Stettner, CEO of FundCanna, to discuss the complexities of cannabis financing. Adam shares his journey from the apparel industry to cannabis, emphasizing the importance of understanding the unique challenges of underwriting in this space. He highlights the need for a client-centric approach in lending, the significance of transparency, and the innovative strategies FunCounter employs to navigate the cannabis market. Adam also discusses the importance of knowledge sharing and the metrics that indicate success in cannabis financing. In this conversation, Adam Stettner discusses the importance of building partnerships in the cannabis industry, focusing on how funding can enhance operational efficiency and support business growth. He emphasizes the need for flexible financial solutions that allow businesses to thrive without being constrained by debt. Stettner also highlights the significance of understanding technology and its impact on business operations, advocating for a metrics-based approach to financial decisions. The discussion concludes with insights on leveraging debt as a tool for growth and the importance of fostering relationships in the industry.
How LEVEL Delivers Effects-Based Cannabis Tablets ft. Chris Emerson
Épisode 280
jeudi 20 novembre 2025 • Durée 48:17
Everyone in cannabis talks about effects-based products — almost no one can deliver them consistently.
Repeatable experiences require precision and formulation discipline that looks a lot more like pharma than cannabis.
And here’s why: most operators don’t treat in-house analytics as essential. But that’s the mistake.
Process control isn’t optional — it’s the foundation for delivering the same experience every single time.
This week we sit down with Chris Emerson, Founder of LEVEL, to break down: • How true effects-based products are actually built • The analytics and standardization required for repeatability • Why most teams can’t achieve consistency — and what it takes to fix it
Chapters
00:00 Introduction to Chris Emerson and Level
03:07 The Journey into Cannabis and Product Development
06:02 Challenges in Consistency and Formulation
08:48 Navigating the Market and Consumer Education
12:05 The Role of Cannabinoids and Future Innovations
14:56 Expanding Beyond California: Challenges and Strategies
27:32 The Importance of Consistency in Product Quality
29:51 Navigating the Medical vs Recreational Cannabis Landscape
33:03 Advanced Analytics in Cannabis Production
36:02 Innovations in Product Formulation and Consumer Experience
39:56 Strategic Approaches to Hemp and Cannabinoid Research
45:00 Exploring the Future of Cannabinoids and Consumer Education
What Tobacco and Alcohol Taught Me About Cannabis. ft. Nick Kenny
Épisode 279
vendredi 14 novembre 2025 • Durée 40:58
Tobacco and alcohol are already laying the groundwork for cannabis — building IP, infrastructure, and data.
Nick Kenney breaks down what legacy industries already understand — how regulated markets are built, and why readiness always beats speed.
This week we sit down with Nick Kenny to discuss: • How tobacco and alcohol are entering cannabis • The playbook for building standardized, scalable systems • Why predictability and timing will define the next wave of winners
Chapters
00:00 Introduction to the Cannabis Industry Journey
02:54 The Evolution of Cannabis Perception
06:02 Navigating Regulatory Challenges
08:48 Tobacco and Alcohol Industry Perspectives
11:59 The Role of Research and Development
14:58 Long-Term Strategies vs. Short-Term Survival
18:10 Consumer Behavior and Market Trends
21:03 The Importance of Data in Decision Making
23:58 Collaboration and Networking in the Industry
27:04 Future Outlook and Industry Innovations
Summary
In this episode, Bryan Fields and Kellan Finney engage with Nick Kenney, a Global Strategic Advisor, to explore the evolving landscape of the cannabis industry. Nick shares his journey from the tobacco sector to cannabis, highlighting the significant shifts in perception and investment within the industry. The conversation delves into the regulatory challenges, the perspectives of tobacco and alcohol companies, and the importance of research and development. They discuss the need for long-term strategies, the impact of consumer behavior, and the critical role of data in decision-making. Nick emphasizes the value of networking and collaboration in the cannabis space, while also providing insights into future innovations and market trends.
The Amazon of THC, How Edibles.com Will Take Cannabis National, ft. Thomas Winstanley
Épisode 278
vendredi 7 novembre 2025 • Durée 52:57
Before Target and DoorDash, Edible Arrangements joined the cannabinoid space.
Supply chains look a lot different when you can lean on national infrastructure, logistics, and distribution that already exist.
Through Edibles.com, the company is using that foundation to build access — curating top brands and letting customers shop the way they understand best: by experience.
Could this platform and distribution model become the Amazon of cannabinoids?
This week we sit down with Thomas Winstanley to discuss:
• The strategy and roadmap behind Edibles.com
• Balancing risk and regulation in an uncertain market
• How infrastructure and logistics unlock national access
Chapters
00:00 Introduction to the Cannabis Space
02:56 Thomas Winstanley's Journey in Cannabis
06:06 Understanding Edibles.com
08:50 Curating Products for Consumers
12:01 Building Trust with Brands
15:01 Navigating Market Dynamics
18:10 Supply Chain and Distribution Strategies
27:06 Leveraging Internal Resources for Competitive Advantage
29:32 Exploring Innovative Product Offerings
31:57 Strategic Growth and Investment Considerations
32:31 The Importance of Retail in Consumer Engagement
39:03 Navigating Regulatory Challenges in the Hemp Industry
48:07 Defining Success and Future Opportunities
51:56 Inventory Management and Cost Control
56:02 Preparing for Market Consolidation
58:11 Final Thoughts and Future Directions
About: Nicolas Guarino is Co-Founder and CEO of Jaunty. As a GMP-certified 100% New York company working in cannabis extraction since 2017, Jaunty has been producing and distributing the finest solventless hash, live resin, and distillate cannabis products in its mission to close the gap between flower and oil. With state-of-the-art manufacturing facilities in Hoosick Falls, NY, Jaunty is one of New York's leading companies licensed for all adult-use cannabis supply chain activities outside of retail, including cultivation, processing, manufacturing, and distribution. They produce and distribute one of New York’s best-selling cannabis vape brands, available in all of the state’s licensed dispensaries, and their product portfolio also features gummies, concentrates, and disposable vapes.
Summary
In this episode, Bryan Fields interviews Nicolas Guarino, co-founder and CEO of Jaunty, discussing his journey in the cannabis industry, the challenges faced in the CBD market, and the transition to recreational cannabis. They explore the importance of brand consistency, financial strategies for growth, and the dynamics of the New York cannabis market. Nicholas shares insights on consumer education, market predictions, and the future vision for Jaunty emphasizing the need for adaptability and resilience in a fast-paced industry.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
30:02 The Potential for Pharmaceutical Collaborations
33:04 Looking Ahead: The Future of CBD and Cannabis
36:13 Final Thoughts and Audience Engagement
Summary
In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.
In this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
30:08 The Size of the Global Cannabis Opportunity
31:31 Strategic Partnerships in the US
32:03 Conclusion and Key Takeaways
Summary
In this episode, Tyler Robson, president of Sundial, shares insights into his journey in the cannabis industry, the complexities of extraction and manufacturing, and the challenges of merging companies. He discusses Sundial's global operations, the importance of data-driven decision making, and the need for focus in a distracted industry. Tyler also highlights the potential for growth in emerging markets and the synergies between the cannabis and liquor industries, while emphasizing the significance of strategic partnerships.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Guest Links:
https://fundcanna.com
https://fundcanna.com/about/adam-stettner/
https://www.linkedin.com/in/adamstettner
https://www.linkedin.com/company/fundcanna/
About Adam Stettner:
Adam has 30 years of business, strategy and leadership experience in both Private and Public Companies. In 2021, Adam believed the timing and opportunity was right for him to bring his passion for business, innovative financing and entrepreneurial spirit to the Cannabis sector by creating funding products for all areas of this early stage, growth industry by founding FundCanna. FundCanna provides short term funding to all areas of the sector; cultivators, manufacturers, vendors, suppliers, distributors and retailers. In just its first year, FundCanna has underwritten roughly 3000 files and funded over 500 unique files bringing much needed liquidity and financing solutions to the legal Cannabis industry.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Summary
In this conversation, Chris Emerson, founder of Level, shares his journey from academia to the cannabis industry, discussing the challenges and innovations in product development. He emphasizes the importance of effects-based formulations, consistency in product quality, and the need for consumer education in a rapidly evolving market. The discussion also touches on the future of cannabinoid products and the strategies for expanding into new markets while maintaining quality and consistency. In this conversation, Chris Emerson discusses the complexities of cannabis production, emphasizing the importance of consistency and advanced analytics in ensuring product quality. He explores the challenges faced by the medical cannabis market as it competes with recreational use, and shares insights on the evolving landscape of cannabinoid research, particularly focusing on the Varin class and acidic cannabinoids. The discussion also touches on strategic approaches to hemp and the significance of consumer education in navigating the cannabis industry.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Summary
In this episode, Bryan Fields and Kellen Finney engage with Thomas Winstanley of Edibles.com, exploring his journey in the cannabis industry, the mission of Edibles.com, and the complexities of product curation and market dynamics. Thomas shares insights on building trust with brands, navigating the evolving landscape of cannabis and hemp, and the importance of consumer education in this burgeoning market. In this conversation, Thomas Winstanley discusses the competitive advantages of Edibles.com, the importance of innovative product offerings, and the strategic growth considerations for the company. He emphasizes the significance of retail in enhancing consumer engagement and navigating the regulatory challenges within the hemp industry. Winstanley also outlines his vision for success and future opportunities for Edibles.com, highlighting the need for compliance and adaptability in a rapidly changing market.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Podcasts Similaires Basées sur le Contenu
Découvrez des podcasts liées à The Dime. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !
